相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Decitabine Augments Chemotherapy-Induced PD-L1 Upregulation for PD-L1 Blockade in Colorectal Cancer
Kevin Chih-Yang Huang et al.
CANCERS (2020)
Realizing the Clinical Potential of Immunogenic Cell Death in Cancer Chemotherapy and Radiotherapy
Bernardo L. Rapoport et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Contribution of Resident Memory CD8+ T Cells to Protective Immunity against Respiratory Syncytial Virus and Their Impact on Vaccine Design
Angello Retamal-Diaz et al.
PATHOGENS (2019)
Upregulation of tumor PD-L1 by neoadjuvant chemoradiotherapy (neoCRT) confers improved survival in patients with lymph node metastasis of locally advanced rectal cancers
Shu-Fen Chiang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Pattern Recognition Receptor Polymorphisms as Predictors of Oxaliplatin Benefit in Colorectal Cancer
Victoria Gray et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Priming anti-tumor immunity by radiotherapy: Dying tumor cell-derived DAMPs trigger endothelial cell activation and recruitment of myeloid cells
Julia Krombach et al.
ONCOIMMUNOLOGY (2019)
Intracellular formyl peptide receptor regulates naive CD4 T cell migration
Ha Young Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Inhibition of the AnxA1/FPR1 autocrine axis reduces MDA-MB-231 breast cancer cell growth and aggressiveness in vitro and in vivo
Lara Vecchi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2018)
Clinical significance of programmed death 1 ligand-1 (CD274/PD-L1) and intra-tumoral CD8+T-cell infiltration in stage II-III colorectal cancer
Chih-Yang Huang et al.
SCIENTIFIC REPORTS (2018)
PD-1/PD-L1 Axis, Rather Than High-Mobility Group Alarmins or CD8+ Tumor-Infiltrating Lymphocytes, Is Associated With Survival in Head and Neck Squamous Cell Carcinoma Patients Who Received Surgical Resection
Fan Yang et al.
FRONTIERS IN ONCOLOGY (2018)
Cytosolic high-mobility group box protein 1 (HMGB1) and/or PD-1+TILs in the tumor microenvironment may be contributing prognostic biomarkers for patients with locally advanced rectal cancer who have undergone neoadjuvant chemoradiotherapy
Chih-Yang Huang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
RSF-1 overexpression determines cancer progression and drug resistance in cervical cancer
Xiangyu Wang et al.
BIOMEDICINE-TAIWAN (2018)
Intravital Imaging of Neutrophil Recruitment Reveals the Efficacy of FPR1 Blockade in Hepatic Ischemia- Reperfusion Injury
Masaki Honda et al.
JOURNAL OF IMMUNOLOGY (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Impact of Pattern Recognition Receptors on the Prognosis of Breast Cancer Patients Undergoing Adjuvant Chemotherapy
Erika Vacchelli et al.
CANCER RESEARCH (2016)
Clinical Significance of TLR1 I602S Polymorphism for Patients with Metastatic Colorectal Cancer Treated with FOLFIRI plus Bevacizumab
Satoshi Okazaki et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Damage-associated molecular patterns in cancer: a double-edged sword
C. Hernandez et al.
ONCOGENE (2016)
Yet another pattern recognition receptor involved in the chemotherapy-induced anticancer immune response: Formyl peptide receptor-1
Erika Vacchelli et al.
ONCOIMMUNOLOGY (2016)
Inhibition of formyl peptide receptor 1 reduces the efficacy of anticancer chemotherapy against carcinogen-induced breast cancer
Elisa E. Baracco et al.
ONCOIMMUNOLOGY (2016)
Immunogenic cell death
Abhishek D. Garg et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2015)
Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1
Erika Vacchelli et al.
SCIENCE (2015)
Predictive Biomarkers to Chemoradiation in Locally Advanced Rectal Cancer
Raquel Conde-Muino et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Oncologic impact of pathologic response on clinical outcome after preoperative chemoradiotherapy in locally advanced rectal cancer
Wook Hyeon Yoon et al.
ANNALS OF SURGICAL TREATMENT AND RESEARCH (2015)
Cross-Presentation of the Oncofetal Tumor Antigen 5T4 from Irradiated Prostate Cancer Cells-A Key Role for Heat-Shock Protein 70 and Receptor CD91
Josephine Salimu et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Role of Local Radiation Therapy in Cancer Immunotherapy
Sandra Demaria et al.
JAMA ONCOLOGY (2015)
Myeloid-derived cells are key targets of tumor immunotherapy
Jose Medina-Echeverz et al.
ONCOIMMUNOLOGY (2014)
Preoperative Versus Postoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: Results of the German CAO/ARO/AIO-94 Randomized Phase III Trial After a Median Follow-Up of 11 Years
Rolf Sauer et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Relevance of long-lived CD8(+) T effector memory cells for protective immunity elicited by heterologous prime-boost vaccination
Jose R. Vasconcelos et al.
FRONTIERS IN IMMUNOLOGY (2012)
Frontiers in nephrology: T cell memory as a barrier to transplant tolerance
Anna Valujskikh et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Prognostic value of Dworak grade of regression (GR) in patients with rectal carcinoma treated with preoperative radiochemotherapy
Lorena Losi et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2006)
Effector memory T cells, early metastasis, and survival in colorectal cancer
F Pagès et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer
C Rödel et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
A cell line model for the differentiation of human dendritic cells
C Berges et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Preoperative versus postoperative chemoradiotherapy for rectal cancer
R Sauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Functional differences between human formyl peptide receptor isoforms 26, 98, and G6
K Wenzel-Seifert et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2003)
Differential regulation of formyl peptide receptor-like 1 expression during the differentiation of monocytes to dendritic cells and macrophages
D Yang et al.
JOURNAL OF IMMUNOLOGY (2001)
分享论文
